Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 62, Issue 4, 2007, Pages 434-439

  Kuo, Hsu Ko ^a   Liao, Kuo Chen ^b   Leveille, Suzanne G ^c   Bean, Jonathan F ^d   Yen, Chung Jen ^a   Chen, Jen Hau ^a   Yu, Yau Hua ^e,f   Tai, Tong Yuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c HARVARD MEDICAL SCHOOL   (United States)

^d and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AGING; AMINO ACID BLOOD LEVEL; ARTICLE; DAILY LIFE ACTIVITY; FEMALE; FUNCTIONAL ASSESSMENT; GAIT; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE STRENGTH; NORMAL HUMAN; PHYSICAL DISABILITY; PHYSICAL MOBILITY; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUESTIONNAIRE; WALKING SPEED; BLOOD; DISABILITY; DISABLED PERSON; MIDDLE AGED; NUTRITION; PATHOPHYSIOLOGY; TIME;

ACTIVITIES OF DAILY LIVING; AGED; AGING; DISABILITY EVALUATION; DISABLED PERSONS; FEMALE; GAIT; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; NUTRITION SURVEYS; QUADRICEPS MUSCLE; QUESTIONNAIRES; TIME FACTORS;

EID: 34250362341     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/62.4.434     Document Type: Article

References (30)

1. Booth GL, Wang EE. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. CMAJ. 2000;163:21-29.
2. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
3. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr. 2005;82:442-450.
4. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31-62.
5. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338:1042-1050.
6. Kuo HK, Sorond FA, Chen JH, Hashmi A, Milberg WP, Lipsitz LA. The role of homocysteine in multisystem age-related problems: a systematic review. J Gerontol A Biol Sci Med Sci. 2005;60:1190-1201.
7. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476-483.
8. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350:2033-2041.
9. McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004;350:2042-2049.
10. Kado DM, Bucur A, Selhub J, Rowe JW, Seeman T. Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging. Am J Med. 2002;113:537-542.
11. Manton KG, Corder LS, Stallard E. Estimates of change in chronic disability and institutional incidence and prevalence rates in the U.S. elderly population from the 1982, 1984, and 1989 National Long Term Care Survey. J Gerontol. 1993;48:S153-S66.
12. Marengoni A, Cossi S, De Martinis M, Calabrese PA, Orini S, Grassi V. Homocysteine and disability in hospitalized geriatric patients. Metabolism. 2004;53:1016-1020.
13. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556-561.
14. Ostir GV, Markides KS, Black SA, Goodwin JS. Lower body functioning as a predictor of subsequent disability among older Mexican Americans. J Gerontol Med Sci. 1998;53A:M491-M495.
15. Giampaoli S, Ferrucci L, Cecchi F, et al. Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing. 1999;28:283-288.
16. Shinkai S, Watanabe S, Kumagai S, et al. Walking speed as a good predictor for the onset of functional dependence in a Japanese rural community population. Age Ageing. 2000;29:441-446.
17. Rantanen T, Avlund K, Suominen H, Schroll M, Frandin K, Pertti E. Muscle strength as a predictor of onset of ADL dependence in people aged 75 years. Aging Clin Exp Res. 2002;14(3 suppl):10-15.
18. 1999-2000 National Health and Nutrition Examination Survey (NHANES). Available at http://www.cdc.gov/nchs/about/major/nhanes/currentnhanes.htm. Bethesda, MD: National Center for Health Statistics. Last accessed February 12, 2007.
19. 2001-2002 National Health and Nutrition Examination Survey (NHANES). Available at http://www.cdc.gov/nchs/about/major/nhanes/current_nhanes_01_02. htm. Bethesda, MD: National Center for Health Statistics. Last accessed February 12, 2007.
20. National Health and Nutrition Examination Survey. Muscle Strength Procedures Manual. Available at http://www.cdc.gov/nchs/data/nhanes/ms.pdf. Bethesda, MD: National Center for Health Statistics. Last accessed February 12, 2007.
21. Pfeiffer CM, Huff DL, Smith SJ, Miller DT, Gunter EW. Comparison of plasma total homocysteine measurements in 14 laboratories: an international study. Clin Chem. 199945(8 pt 1): 1261-1268.
22. National Heart, Lung, and Blood Institute. Obesity Education Initiative: The Evidence Report. Bethesda, MD: National Institutes of Health; 1998.
23. Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr. 2000;130(2S suppl):377S-381S.
24. Bostom AG, Rosenberg IH, Silbershatz H, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med. 1999;131:352-355.
25. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003;34:392-396.
26. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol. 2002;51:285-289.
27. Masdeu JC, Wolfson L, Lantos G, et al. Brain white-matter changes in the elderly prone to falling. Arch Neurol. 1989;46:1292-1296.
28. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. BMJ. 1998;316:894-898.
29. Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567-1577.
30. Bonaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578-1588.